GLUCOPHAGE Side Effects

6765924-9 | Blood Bicarbonate Decreased, Blood Lactic Acid Increased, Overdose, Somnolence, Vomiting
on May 27, 2010 Female patient from GERMANY , 59 years of age, weighting 191.8 lb, was treated with Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: blood bicarbonate decreased, blood lactic acid increased, overdose, somnolence, vomiting. Glucophage dosage: Coated Tabs. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LASIX (View Lasix Review and Lasix Label ), CRESTOR (View Crestor Review and Crestor Label ), LERCAN (View Lercan Review and Lercan Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), SERESTA (View Seresta Review and Seresta Label ), ALTEIS (View Alteis Review and Alteis Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

6764855-8 | Lactic Acidosis, Renal Failure
Patient was taking Glucophage (View Usage). Patient had the following side effects: lactic acidosis, renal failure on May 27, 2010 from GERMANY Additional patient health information: Male patient , 69 years of age, was diagnosed with type 2 diabetes mellitus and. Glucophage dosage: . Patient was hospitalized.

6763833-2 | Hepatic Failure
Adverse event was reported on Jun 07, 2010 by a Female patient taking Glucophage (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 84 years of age, After Glucophage was administered, patient had the following side effects: hepatic failure. During the same period patient was treated with PRANDIN (View Prandin Review and Prandin Label ), AVANDIA (View Avandia Review and Avandia Label ). Patient was hospitalized.

6756718-9 | Epistaxis, International Normalised Ratio Increased
on May 25, 2010 Female patient from GERMANY , 71 years of age, weighting 165.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, international normalised ratio increased. Glucophage dosage: Coated Tablet;from Feb2010-13may10;restarted 500mg Bid From 17may10. During the same period patient was treated with MARCUMAR (Taken 1to2df(dates Unk);stopped From 14may10-16may-10;resumed 17may10(3mg)/d,1 Df,1df/wk 1df=0.5tab) (View Marcumar Review and Marcumar Label ), METOPROLOL SUCCINATE (1df = 47.5(units Not Specified)) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), BLOPRESS PLUS (1 Df = 16mg/12.5mg(0.5 Df Daily)) (View Blopress Plus Review and Blopress Plus Label ), TORASEMIDE (1df=0.5df) (View Torasemide Review and Torasemide Label ), NOVODIGAL (View Novodigal Review and Novodigal Label ), LEVOTHYROXINE SODIUM (1df = 75 (units Not Specified)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.


6753043-7 | Arthralgia, Dizziness, Fatigue, Pain In Extremity, Vision Blurred
on Jun 02, 2010 Female patient from UNITED STATES , 70 years of age, weighting 130.0 lb, was treated with Glucophage (View Usage). Patient had the following side effects: arthralgia, dizziness (What is dizziness?), fatigue, pain in extremity, vision blurred. Glucophage dosage: 2 X 500 Mg Per Day.

6748200-X | Lactic Acidosis, Renal Failure Acute
Patient was taking Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: lactic acidosis, renal failure acute on May 21, 2010 from GERMANY Additional patient health information: Female patient , 62 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, respiratory tract infection, blood cholesterol increased, prophylaxis and. Glucophage dosage: . During the same period patient was treated with MICARDIS HCT (1 Df = 1 Sachet;tab) (View Micardis Hct Review and Micardis Hct Label ), ERYMAX (View Erymax Review and Erymax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ALBYL E (View Albyl-e Review and Albyl-e Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6748025-5 | Lactic Acidosis, Pancreatitis Acute, Renal Failure
Adverse event was reported on May 17, 2010 by a Female patient taking Glucophage (View Usage) (Dosage: Glucophage 500mg) was diagnosed with diabetes mellitus, bipolar i disorder and. Location: GERMANY , 81 years of age, Patient experienced the following unwanted or unexpected effects: lactic acidosis, pancreatitis acute, renal failure. During the same period patient was treated with TEGRETOL (1 Df=200mg Tablet. Started 5-10 Years Ago.) (View Tegretol Review and Tegretol Label ), SELOKEN (View Seloken Review and Seloken Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DEROXAT (View Deroxat Review and Deroxat Label ). Patient was hospitalized.

6745865-3 | Hepatic Failure
on May 25, 2010 Female patient from UNITED STATES , 84 years of age, was diagnosed with diabetes mellitus and was treated with Glucophage (View Usage). Patient had the following side effects: hepatic failure. Glucophage dosage: . During the same period patient was treated with PRANDIN (View Prandin Review and Prandin Label ), AVANDIA (View Avandia Review and Avandia Label ). Patient was hospitalized.

6745840-9 | Fall, Lactic Acidosis, Lung Disorder
on May 17, 2010 Male patient from GERMANY , 69 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: fall (What is fall?), lactic acidosis, lung disorder. Glucophage dosage: . During the same period patient was treated with SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), MOPRAL (View Mopral Review and Mopral Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), FORADIL (View Foradil Review and Foradil Label ). Patient was hospitalized.

6743370-1 | Metabolic Acidosis, Renal Failure, Respiratory Acidosis
Patient was taking Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: metabolic acidosis, renal failure, respiratory acidosis on May 17, 2010 from GERMANY Additional patient health information: Male patient , 62 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, atrial fibrillation (What is atrial fibrillation?) and. Glucophage dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LANTUS (View Lantus Review and Lantus Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), AMLOR (View Amlor Review and Amlor Label ), COVERSYL (View Coversyl Review and Coversyl Label ), FLUDEX (View Fludex Review and Fludex Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

6742367-5 | Renal Failure
Adverse event was reported on May 24, 2010 by a Male patient taking Glucophage (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 70 years of age, weighting 220.5 lb, Patient had the following side effects: renal failure. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), NEFAZODONE HCL (View Nefazodone Hcl Review and Nefazodone Hcl Label ).

6742360-2 | Cytolytic Hepatitis
on May 17, 2010 Male patient from GERMANY , 62 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, back pain (What is back pain?), joint prosthesis user and was treated with Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: cytolytic hepatitis. Glucophage dosage: . During the same period patient was treated with ALCOHOL (View Alcohol Review and Alcohol Label ), EXFORGE (Started Several Yrs Ago-ong.) (View Exforge Review and Exforge Label ), SKENAN (Started Several Yrs Ago-ong.) (View Skenan Review and Skenan Label ), MORPHINE SULFATE (Started Several Yrs Ago-ong.) (View Morphine Sulfate Review and Morphine Sulfate Label ).

6736460-0 | Euphoric Mood, Feeling Of Despair, Suicidal Ideation
on Apr 23, 2007 Male patient from UNITED STATES , 52 years of age, weighting 264.6 lb, was diagnosed with diabetes mellitus and was treated with Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: euphoric mood, feeling of despair, suicidal ideation. Glucophage dosage: . During the same period patient was treated with RELAFEN (View Relafen Review and Relafen Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), DIOVAN (View Diovan Review and Diovan Label ), PRILOSEC (View Prilosec Review and Prilosec Label ).

6726135-6 | Epistaxis, International Normalised Ratio Increased
Patient was taking Glucophage (View Usage). Patient had the following side effects: epistaxis, international normalised ratio increased on May 03, 2010 from GERMANY Additional patient health information: Female patient , 71 years of age, weighting 165.3 lb, was diagnosed with type 2 diabetes mellitus and. Glucophage dosage: Coated Tablet. During the same period patient was treated with MARCUMAR (Marcumar 3 Mg (0.5 Df On 6 Days/week And 1 Df Once Weekly) Also Taken 1df/week,1df/day,2010) (View Marcumar Review and Marcumar Label ), METOPROLOL SUCCINATE (Beloc Zok Mite 47.5) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), BLOPRESS PLUS (0.5df=16mg +12.5mg) (View Blopress Plus Review and Blopress Plus Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), NOVODIGAL (Novodigal 0.2) (View Novodigal Review and Novodigal Label ), LEVOTHYROXINE SODIUM (L-thyroxine 75) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6725352-9 | Hemiplegia, Hypoglycaemic Coma
Adverse event was reported on May 05, 2010 by a Male patient taking Glucophage (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, coronary artery disease (What is coronary artery disease?) and. Location: GERMANY , 66 years of age, After Glucophage was administered, patient had the following side effects: hemiplegia, hypoglycaemic coma. During the same period patient was treated with CARDENSIEL (1df=2.5 Mg Tablet) (View Cardensiel Review and Cardensiel Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), PRAXILENE (Praxilene 200mg) (View Praxilene Review and Praxilene Label ), PRAVASTATIN SODIUM (1 Df) (View Pravastatin Sodium Review and Pravastatin Sodium Label ), FONZYLANE (150mg Tab) (View Fonzylane Review and Fonzylane Label ), COTAREG (Cotareg 160mg Tab) (View Cotareg Review and Cotareg Label ), PLAVIX (Plavix 75mg Tab) (View Plavix Review and Plavix Label ), CONTRAMAL (Contramal 50mg) (View Contramal Review and Contramal Label ). Patient was hospitalized.

6725351-7 | Dehydration, Hyperglycaemia, Vomiting
on May 07, 2010 Female patient from GERMANY , 53 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, hyperglycaemia, vomiting. Glucophage dosage: 25jan2010 Doubled The Daily Dose;coated Tablet.. During the same period patient was treated with BYETTA (Strength: 10mcg;form: Soln For Inj; 25jan2010 Doubled The Daily Dose.) (View Byetta Review and Byetta Label ). Patient was hospitalized.

6723473-8 | Hepatitis, Pulmonary Sarcoidosis
on May 05, 2010 Female patient from GERMANY , 39 years of age, was treated with Glucophage (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?), pulmonary sarcoidosis. Glucophage dosage: . During the same period patient was treated with AMLOR (View Amlor Review and Amlor Label ). Patient was hospitalized.

6717109-X | Hypoglycaemia
Patient was taking Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: hypoglycaemia on Apr 30, 2010 from GERMANY Additional patient health information: Male patient , 53 years of age, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia and. Glucophage dosage: 1000mg. During the same period patient was treated with SOLOSA (Was Receiving 2mg (17dec08-unk) Dose Increased To 4mg From 11jan2010) (View Solosa Review and Solosa Label ), VYTORIN (1 Df = 10mg/20mg) (View Vytorin Review and Vytorin Label ).

6717090-3 | Hypoglycaemia, Sopor
Adverse event was reported on Apr 29, 2010 by a Male patient taking Glucophage (View Usage) (Dosage: Glucophage 1000mg) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , 60 years of age, Patient experienced the following unwanted or unexpected effects: hypoglycaemia, sopor. During the same period patient was treated with REPAGLINIDE (1df-1 U (5mg+ 500mg)) (View Repaglinide Review and Repaglinide Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6716980-5 | Ill-defined Disorder
on May 06, 2010 Male patient from UNITED STATES , weighting 180.0 lb, was treated with Glucophage (View Usage). Patient had the following side effects: ill-defined disorder. Glucophage dosage: Daily Oral. During the same period patient was treated with GLIPIZIDE (Daily Oral) (View Glipizide Review and Glipizide Label ).

6715260-1 | Dehydration, Hypoglycaemia, Lactic Acidosis, Renal Failure Acute, Vomiting
on Apr 28, 2010 Female patient from GERMANY , 82 years of age, was treated with Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: dehydration, hypoglycaemia, lactic acidosis, renal failure acute, vomiting. Glucophage dosage: . During the same period patient was treated with PRITOR (Tabs) (View Pritor Review and Pritor Label ), DIAMICRON (Modified Release Tabs) (View Diamicron Review and Diamicron Label ). Patient was hospitalized.

6712983-5 | Gastroenteritis, Haemoptysis, Ischaemic Stroke, Lactic Acidosis
Patient was taking Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: gastroenteritis (What is gastroenteritis?), haemoptysis, ischaemic stroke, lactic acidosis on Apr 27, 2010 from GERMANY Additional patient health information: Male patient , 63 years of age, . Glucophage dosage: .

6711271-0 | Photosensitivity Reaction
Adverse event was reported on Apr 26, 2010 by a Female patient taking Glucophage (View Usage) (Dosage: 1df:2 Tabs) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , 54 years of age, Patient had the following side effects: photosensitivity reaction.

6711270-9 | Photosensitivity Reaction
on Apr 26, 2010 Female patient from GERMANY , 73 years of age, was diagnosed with type 2 diabetes mellitus, essential hypertension and was treated with Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: photosensitivity reaction. Glucophage dosage: . During the same period patient was treated with AVLOCARDYL (1 Df =avlocardyl 40 Tabs) (View Avlocardyl Review and Avlocardyl Label ).

6709912-7 | Diarrhoea, Lactic Acidosis, Renal Failure Acute
on Apr 25, 2010 Female patient from GERMANY , 85 years of age, weighting 141.1 lb, was treated with Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, lactic acidosis, renal failure acute. Glucophage dosage: . Patient was hospitalized.

6709897-3 | Lactic Acidosis, Renal Failure Acute
Patient was taking Glucophage (View Usage). Patient had the following side effects: lactic acidosis, renal failure acute on Apr 25, 2010 from GERMANY Additional patient health information: Female patient , 68 years of age, weighting 209.4 lb, was diagnosed with type 2 diabetes mellitus and. Glucophage dosage: Glucophage 1000mg. Patient was hospitalized.

6705358-6 | Lymphadenopathy
Adverse event was reported on Apr 20, 2010 by a Female patient taking Glucophage (View Usage) (Dosage: 166.6667mg) was diagnosed with polycystic ovaries and. Location: GERMANY , 36 years of age, After Glucophage was administered, patient had the following side effects: lymphadenopathy.

6705357-4 | Eosinophilia, Rash
on Apr 21, 2010 Female patient from GERMANY , 72 years of age, was treated with Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, rash (What is rash?). Glucophage dosage: Formulation: Tablet. During the same period patient was treated with ROCEPHIN (Dosage Form - 1g, Powder For Solution For Injection) (View Rocephin Review and Rocephin Label ), SINTROM (Formulation: Tablet) (View Sintrom Review and Sintrom Label ), EFFEXOR (Formulation: Tablet) (View Effexor Review and Effexor Label ), COZAAR (View Cozaar Review and Cozaar Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LOXEN (View Loxen Review and Loxen Label ), NEXIUM (View Nexium Review and Nexium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6702305-8 | Abscess, Acute Respiratory Failure, Electrolyte Imbalance, Haemoglobin Decreased, Lactic Acidosis, Malaise, Metabolic Acidosis, Renal Failure Acute, Sepsis
on Apr 19, 2010 Male patient from GERMANY , 62 years of age, weighting 246.9 lb, was diagnosed with type 2 diabetes mellitus, immunisation and was treated with Glucophage (View Usage). Patient had the following side effects: abscess (What is abscess?), acute respiratory failure, electrolyte imbalance, haemoglobin decreased, lactic acidosis, malaise, metabolic acidosis, renal failure acute, sepsis (What is sepsis?). Glucophage dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), PANDEMRIX (Sachet) (View Pandemrix Review and Pandemrix Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6693837-X | Blood Creatinine Increased, Blood Potassium Increased, Dehydration, Diarrhoea, Lactic Acidosis, Oliguria
Patient was taking Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: blood creatinine increased, blood potassium increased, dehydration, diarrhoea, lactic acidosis, oliguria on Apr 12, 2010 from GERMANY Additional patient health information: Female patient , 83 years of age, . Glucophage dosage: . During the same period patient was treated with IRBESARTAN + HCTZ (1df:irbesartan 300mg/hctz 25mg) (View Irbesartan + Hctz Review and Irbesartan + Hctz Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6692186-3 | Chest Pain, Dehydration, Diarrhoea, Grand Mal Convulsion, Renal Failure Acute, Renal Tubular Necrosis, Vomiting
Adverse event was reported on Apr 13, 2010 by a Female patient taking Glucophage (View Usage) (Dosage: ) . Location: GERMANY , 52 years of age, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dehydration, diarrhoea, grand mal convulsion, renal failure acute, renal tubular necrosis, vomiting. During the same period patient was treated with IOMERON 150 (View Iomeron-150 Review and Iomeron-150 Label ), OMNIPAQUE 140 (View Omnipaque 140 Review and Omnipaque 140 Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), ZOLPIDEM (Tablet) (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6687987-1 | Hypoglycaemia
on Apr 08, 2010 Male patient from GERMANY , 53 years of age, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia and was treated with Glucophage (View Usage). Patient had the following side effects: hypoglycaemia. Glucophage dosage: 1000mg. During the same period patient was treated with SOLOSA (Was Receiving 2mg (17dec08-unk) Dose Increased To 4mg From 11jan2010) (View Solosa Review and Solosa Label ), VYTORIN (1 Df = 10mg/20mg) (View Vytorin Review and Vytorin Label ).

6686876-6 | Cholestasis, Dehydration, Lactic Acidosis, Renal Failure, Vomiting
on Apr 08, 2010 Male patient from GERMANY , 76 years of age, was diagnosed with type 1 diabetes mellitus, pain (What is pain?), infection (What is infection?) and was treated with Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: cholestasis, dehydration, lactic acidosis, renal failure, vomiting. Glucophage dosage: . During the same period patient was treated with PARACETAMOL TABS (View Paracetamol Tabs Review and Paracetamol Tabs Label ), RIFAMPICIN (Iv: 5-6nov09(1 Day); 13-17nov09 (4 Days) Oral:18-25nov09(7 Days) Form: Inj) (View Rifampicin Review and Rifampicin Label ), AMOXICILLIN (2 Gram: Soln For Inj) (View Amoxicillin Review and Amoxicillin Label ), CONTRAMAL (Tabs) (View Contramal Review and Contramal Label ). Patient was hospitalized.

6682416-6 | Abdominal Pain Upper, Asthenia, Metabolic Acidosis, Nausea, Pancreatitis, Sepsis, Tachycardia, Tachypnoea, Urinary Tract Infection
Patient was taking Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, asthenia, metabolic acidosis, nausea (What is nausea?), pancreatitis, sepsis (What is sepsis?), tachycardia, tachypnoea, urinary tract infection (What is urinary tract infection?) on Apr 14, 2010 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 136.2 lb, was diagnosed with type 2 diabetes mellitus and. Glucophage dosage: 1500 Mg + 1000 Mg Qam + Qpm Oral. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), LYRICA (View Lyrica Review and Lyrica Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

6681592-9 | Escherichia Urinary Tract Infection, Hyperlactacidaemia, Lactic Acidosis, Metabolic Acidosis, Pulmonary Embolism, Renal Failure Acute, Respiratory Distress, Vomiting
Adverse event was reported on Apr 06, 2010 by a Male patient taking Glucophage (View Usage) (Dosage: ) was diagnosed with insulin-requiring type 2 diabetes mellitus and. Location: GERMANY , 64 years of age, Patient had the following side effects: escherichia urinary tract infection, hyperlactacidaemia, lactic acidosis, metabolic acidosis, pulmonary embolism (What is pulmonary embolism?), renal failure acute, respiratory distress, vomiting. During the same period patient was treated with APROVEL (View Aprovel Review and Aprovel Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TRIATEC (View Triatec Review and Triatec Label ), BI PROFENID (View Bi-profenid Review and Bi-profenid Label ), XENETIX (View Xenetix Review and Xenetix Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), TAHOR (View Tahor Review and Tahor Label ), ESIDRIX (View Esidrix Review and Esidrix Label ). Patient was hospitalized.

6670876-6 | Cyanosis, Lactic Acidosis, Pancreatitis Acute, Renal Failure Acute, Shock
on Mar 31, 2010 Female patient from GERMANY , 61 years of age, was treated with Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: cyanosis, lactic acidosis, pancreatitis acute, renal failure acute, shock. Glucophage dosage: . During the same period patient was treated with OLMESARTAN MEDOXOMIL + HCTZ (View Olmesartan Medoxomil + Hctz Review and Olmesartan Medoxomil + Hctz Label ), ACTOS (View Actos Review and Actos Label ).

6670315-5 | Hypoglycaemia
on Mar 30, 2010 Male patient from GERMANY , 53 years of age, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia and was treated with Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Glucophage dosage: . During the same period patient was treated with SOLOSA (Was Receiving 2mg (17dec08-unk) Dose Increased To 4mg From 11jan2010) (View Solosa Review and Solosa Label ), VYTORIN (1 Df = 10mg/20mg) (View Vytorin Review and Vytorin Label ).

6653259-4 | Lactic Acidosis, Renal Failure Acute
Patient was taking Glucophage (View Usage). Patient had the following side effects: lactic acidosis, renal failure acute on Mar 18, 2010 from FRANCE Additional patient health information: Male patient , 78 years of age, was diagnosed with type 2 diabetes mellitus, hypertension and. Glucophage dosage: Coated Tabs. During the same period patient was treated with CAPTOPRIL (1df) (View Captopril Review and Captopril Label ), ECAZIDE (1df = 1cap) (View Ecazide Review and Ecazide Label ), HEMI DAONIL (View Hemi-daonil Review and Hemi-daonil Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6648998-5 | Anaemia, Diarrhoea, Lactic Acidosis, Renal Failure Acute, Vomiting
Adverse event was reported on Mar 15, 2010 by a Female patient taking Glucophage (View Usage) (Dosage: ) . Location: GERMANY , 76 years of age, After Glucophage was administered, patient had the following side effects: anaemia, diarrhoea, lactic acidosis, renal failure acute, vomiting. During the same period patient was treated with ADVIL LIQUI GELS (Form=tabs) (View Advil Liqui-gels Review and Advil Liqui-gels Label ), FUROSEMIDE (1dform=1tabs,20mg) (View Furosemide Review and Furosemide Label ), PRITOR (View Pritor Review and Pritor Label ), GLUCOR (View Glucor Review and Glucor Label ), VASTAREL (View Vastarel Review and Vastarel Label ), AMAREL (View Amarel Review and Amarel Label ), MOGADON (View Mogadon Review and Mogadon Label ), POLERY (View Polery Review and Polery Label ). Patient was hospitalized.

6648147-3 | Anaemia, Cardiac Failure, Lactic Acidosis, Renal Failure
on Mar 15, 2010 Female patient from GERMANY , 78 years of age, weighting 132.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cardiac failure, lactic acidosis, renal failure. Glucophage dosage: . During the same period patient was treated with KARDEGIC (Tabs) (View Kardegic Review and Kardegic Label ), SEROPLEX (Tabs) (View Seroplex Review and Seroplex Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), TRIATEC (View Triatec Review and Triatec Label ), IMOVANE (View Imovane Review and Imovane Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), FIXICAL (View Fixical Review and Fixical Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

6646806-X | Accident, Cardio-respiratory Arrest, Heart Injury, Lactic Acidosis, Multi-organ Failure, Renal Failure Acute, Sternal Fracture
on Mar 15, 2010 Male patient from GERMANY , 78 years of age, was treated with Glucophage (View Usage). Patient had the following side effects: accident, cardio-respiratory arrest, heart injury, lactic acidosis, multi-organ failure, renal failure acute, sternal fracture. Glucophage dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), RENITEC (View Renitec Review and Renitec Label ), GLUCOR (View Glucor Review and Glucor Label ), PRAXILENE (View Praxilene Review and Praxilene Label ). Patient was hospitalized.

6645919-6 | Malaise, Product Odour Abnormal, Shock
Patient was taking Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: malaise, product odour abnormal, shock on Mar 15, 2010 from UNITED STATES Additional patient health information: Female patient , 83 years of age, was diagnosed with diabetes mellitus and. Glucophage dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), DEMADEX (View Demadex Review and Demadex Label ), COUMADIN (View Coumadin Review and Coumadin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ESTRACE (View Estrace Review and Estrace Label ), HUMULIN INSULIN (View Humulin Insulin Review and Humulin Insulin Label ).

6644685-8 | Lactic Acidosis, Renal Failure Acute
Adverse event was reported on Mar 18, 2010 by a Male patient taking Glucophage (View Usage) (Dosage: Coated Tabs) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: FRANCE , 78 years of age, Patient experienced the following unwanted or unexpected effects: lactic acidosis, renal failure acute. During the same period patient was treated with CAPTOPRIL (1df) (View Captopril Review and Captopril Label ), ECAZIDE (1df = 1cap) (View Ecazide Review and Ecazide Label ), PLAVIX (View Plavix Review and Plavix Label ), HEMI DAONIL (View Hemi-daonil Review and Hemi-daonil Label ). Patient was hospitalized.

6644681-0 | Escherichia Urinary Tract Infection, Hyperlactacidaemia, Lactic Acidosis, Metabolic Acidosis, Pulmonary Embolism, Renal Failure Acute, Respiratory Distress, Vomiting
on Mar 15, 2010 Male patient from GERMANY , 65 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Glucophage (View Usage). Patient had the following side effects: escherichia urinary tract infection, hyperlactacidaemia, lactic acidosis, metabolic acidosis, pulmonary embolism (What is pulmonary embolism?), renal failure acute, respiratory distress, vomiting. Glucophage dosage: . During the same period patient was treated with IRBESARTAN (View Irbesartan Review and Irbesartan Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TRIATEC (View Triatec Review and Triatec Label ), BI PROFENID (View Bi-profenid Review and Bi-profenid Label ), XENETIX (View Xenetix Review and Xenetix Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), TAHOR (View Tahor Review and Tahor Label ), ESIDRIX (View Esidrix Review and Esidrix Label ). Patient was hospitalized.

6643957-0 | Leukocytoclastic Vasculitis
on Mar 11, 2010 Female patient from GERMANY , 62 years of age, was diagnosed with diabetes mellitus and was treated with Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: leukocytoclastic vasculitis. Glucophage dosage: 9dec09-15dec:1000mg Dose Increased From 15dec09-20dec09: 850mg[2 In 1 D]. Patient was hospitalized.

6642155-4 | Hyperkalaemia, Lactic Acidosis, Renal Failure
Patient was taking Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, lactic acidosis, renal failure on Mar 11, 2010 from GERMANY Additional patient health information: Female patient , 62 years of age, was diagnosed with type 2 diabetes mellitus, bronchitis (What is bronchitis?) and. Glucophage dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), ATACAND (View Atacand Review and Atacand Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ). Patient was hospitalized.

6639875-4 | Anaemia Macrocytic
Adverse event was reported on Mar 08, 2010 by a Male patient taking Glucophage (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: GERMANY , 79 years of age, Patient had the following side effects: anaemia macrocytic. During the same period patient was treated with NOVONORM (View Novonorm Review and Novonorm Label ). Patient was hospitalized.

6634953-8 | Diarrhoea, Hyperkalaemia, Lactic Acidosis, Renal Failure Acute, Vomiting
on Mar 09, 2010 Male patient from GERMANY , 76 years of age, was treated with Glucophage (View Usage). After Glucophage was administered, patient had the following side effects: diarrhoea, hyperkalaemia, lactic acidosis, renal failure acute, vomiting. Glucophage dosage: Total Dose 2550 Mg Per Day.. During the same period patient was treated with DIAMICRON (View Diamicron Review and Diamicron Label ), INSULATARD (View Insulatard Review and Insulatard Label ), KERLONE (View Kerlone Review and Kerlone Label ). Patient was hospitalized.

6623474-4 | Hypoglycaemia, Sopor
on Mar 01, 2010 Male patient from GERMANY , 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucophage (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, sopor. Glucophage dosage: Glucophage 1000mg. During the same period patient was treated with GLICONORM (1df-1 U (5mg+ 500mg)) (View Gliconorm Review and Gliconorm Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6620314-4 | Abdominal Pain, Diarrhoea, Nausea
Patient was taking Glucophage (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, nausea (What is nausea?) on Mar 08, 2010 from UNITED STATES Additional patient health information: Female patient , 30 years of age, was diagnosed with diabetes mellitus and. Glucophage dosage: Po.